The stroma-a key regulator in prostate function and malignancy
about
Vitamin D and Immune Response: Implications for Prostate Cancer in African AmericansProstate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristicsTMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers.Characterization of a Gene Expression Signature in Normal Rat Prostate Tissue Induced by the Presence of a Tumor Elsewhere in the Organ.Adaptive (TINT) Changes in the Tumor Bearing Organ Are Related to Prostate Tumor Size and Aggressiveness.Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor GrowthSix stroma-based RNA markers diagnostic for prostate cancer in European-Americans validated at the RNA and protein levels in patients in China.Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis.CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment.Pyrrole-imidazole polyamide targeted to break fusion sites in TMPRSS2 and ERG gene fusion represses prostate tumor growth.Extracellular Vesicles from Metastatic Rat Prostate Tumors Prime the Normal Prostate Tissue to Facilitate Tumor Growth.Reactive oxygen species-mediated switching expression of MMP-3 in stromal fibroblasts and cancer cells during prostate cancer progression.Clinical relevance of androgen receptor alterations in prostate cancer.Highly aggressive rat prostate tumors rapidly precondition regional lymph nodes for subsequent metastatic growth.Reduced number of CD169+ macrophages in pre-metastatic regional lymph nodes is associated with subsequent metastatic disease in an animal model and with poor outcome in prostate cancer patients.Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness.Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation.The effect of testosterone treatment on prostate histology and apoptosis in men with late-onset hypogonadism.Extracellular Vesicles in Prostate Cancer Carcinogenesis, Diagnosis, and Management.
P2860
Q26768536-1EF208A9-4DA2-40C7-90A8-AE44AEDD1D43Q26773613-79F722EA-C042-4A3B-B2C5-E743CBB6D754Q35088099-1243465D-7937-426F-A024-F03C88A08E38Q35664216-375CA964-23E1-4BE6-8A70-D0B2355FAF2BQ35832067-D8462B13-111F-4433-BC7F-99488FA5B3B1Q36046653-EAEF0EBA-6E65-4F35-8D12-BE3480A52C7BQ36140962-3898C527-AE41-40A8-871F-8E0DA75A36E1Q36363019-D1E336DF-DA08-44F1-8001-6442C8C737FBQ36974090-586D480B-8E73-484E-9D79-BB86FEDFB6D0Q38969070-02C1CC6E-56CA-4ED8-9176-710390896EF6Q39465138-005A2672-BB9D-40F7-BA54-3A78095C5783Q41489569-5F8D5950-C7D5-4B8C-8F9F-ED9B1C2C60D7Q42377108-246D695D-289F-4157-9CFC-3FCF9B14988DQ46166018-31ACC465-512F-4682-B56D-F1BC4FE4337DQ47112998-5CB872B9-929F-48D2-A827-87E6C0445DE8Q47282721-2C61F06C-A5CE-45F9-BE71-925ACAF98169Q47404758-D2175846-B58E-489C-848E-C048C98B8142Q53160861-6ABC35C0-FEF4-4E16-87B2-7D93268BCA8CQ55342189-59B62485-14CF-48BD-9475-45E11C830660
P2860
The stroma-a key regulator in prostate function and malignancy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 May 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The stroma-a key regulator in prostate function and malignancy
@en
The stroma-a key regulator in prostate function and malignancy.
@nl
type
label
The stroma-a key regulator in prostate function and malignancy
@en
The stroma-a key regulator in prostate function and malignancy.
@nl
prefLabel
The stroma-a key regulator in prostate function and malignancy
@en
The stroma-a key regulator in prostate function and malignancy.
@nl
P2860
P356
P1433
P1476
The stroma-a key regulator in prostate function and malignancy
@en
P2093
Anders Bergh
Christina Hägglöf
P2860
P304
P356
10.3390/CANCERS4020531
P577
2012-05-29T00:00:00Z